Bioequivalence of a novel high-dose oral formulation of alpha-dihydroergocryptine.

de Mey, Christian; Stamenova, Paraskeva; Daskalov, Marin; Orozova, Milka; Staikov, Ivan; Vlahov, Vitan; Wangemann, Martina

de Mey, Christian; Stamenova, Paraskeva; Daskalov, Marin; Orozova, Milka; Staikov, Ivan; Vlahov, Vitan; Wangemann, Martina.

Affiliation

de Mey C; ACPS - Applied Clinical Pharmacology Services, Mainz-Kastel, Germany. C.deMey@ACPS-Network.com

Arzneimittelforschung ; 56(3): 205-11, 2006.

Article in En | MEDLINE | ID: mdl-16618013

Subject(s)

Dihydroergocryptine/pharmacokinetics; Vasodilator Agents/pharmacokinetics; Aged; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Dihydroergocryptine/administration & dosage; Dihydroergocryptine/chemistry; Double-Blind Method; Female; Humans; Male; Mass Spectrometry; Middle Aged; Tablets; Therapeutic Equivalency; Vasodilator Agents/administration & dosage; Vasodilator Agents/chemistry

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vasodilator Agents / Dihydroergocryptine Type of study: Clinical_trials / Prognostic_studies Aspects: Ethics Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Arzneimittelforschung Year: 2006 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links